Nat Struct Mol Biol, 2025, 32(3):418-430

Guidelines for minimal reporting requirements, design and interpretation of experiments involving the use of eukaryotic dual gene expression reporters (MINDR)

Dual reporters encoding two distinct proteins within the same mRNA have had a crucial role in identifying and characterizing unconventional mechanisms of eukaryotic translation. These mechanisms include initiation via internal ribosomal entry sites (IRESs), ribosomal frameshifting, stop codon readthrough and reinitiation. This design enables the expression of one reporter to be influenced by the specific mechanism under investigation, while the other reporter serves as an internal control. However, challenges arise when intervening test sequences are placed between these two reporters. Such sequences can inadvertently impact the expression or function of either reporter, independent of translation-related changes, potentially biasing the results. These effects may occur due to cryptic regulatory elements inducing or affecting transcription initiation, splicing, polyadenylation and antisense transcription as well as unpredictable effects of the translated test sequences on the stability and activity of the reporters. Unfortunately, these unintended effects may lead to misinterpretation of data and the publication of incorrect conclusions in the scientific literature. To address this issue and to assist the scientific community in accurately interpreting dual-reporter experiments, we have developed comprehensive guidelines. These guidelines cover experimental design, interpretation and the minimal requirements for reporting results. They are designed to aid researchers conducting these experiments as well as reviewers, editors and other investigators who seek to evaluate published data.

Loughran G, Andreev DE, Terenin IM, Namy O, Mikl M, Yordanova MM, McManus CJ, Firth AE, Atkins JF, Fraser CS, Ignatova Z, Iwasaki S, Kufel J, Larsson O, Leidel SA, Mankin AS, Mariotti M, Tanenbaum ME, Topisirovic I, Vázquez-Laslop N, Viero G, Caliskan N, Chen Y, Clark PL, Dinman JD, Farabaugh PJ, Gilbert WV, Ivanov P, Kieft JS, Mühlemann O, Sachs MS, Shatsky IN, Sonenberg N, Steckelberg AL, Willis AE, Woodside MT, Valasek LS, Dmitriev SE, Baranov PV

IBCH: 11867
Ссылка на статью в журнале: https://www.nature.com/articles/s41594-025-01492-x
Нет данных о цитировании
Данные статьи проверены модераторами 2025-03-30

Список научных проектов, где отмечена публикация

  1. 210692/Z/18/. . Внебюджетное финансирование.
  2. 20/FFP-A/8929. . Внебюджетное финансирование.
  3. 23-08669L. . Внебюджетное финансирование.
  4. CZ.02.01.01/00/22_008/0004575. . Внебюджетное финансирование.
  5. 23-14-00218. . Внебюджетное финансирование.
  6. R35 GM152137. . Внебюджетное финансирование.
  7. R01GM132358. . Внебюджетное финансирование.
  8. R01GM130838. . Внебюджетное финансирование.
  9. IRCLA/2019/74. . Внебюджетное финансирование.
  10. Системaтический анализ трансляции коротких Открытых Рамок Считывания (кОРC) и исследование свойств их пептидных продуктов (6 Января 2020 года — 31 Декабря 2024 года). Андреев Д.Е., Баранов П.В.. Грант, РНФ.
  11. RYC2019-027746-I. . Внебюджетное финансирование.
  12. PID2020-115122GA-I00. . Внебюджетное финансирование.
  13. PID2023-147164NB-I00. . Внебюджетное финансирование.
  14. MCIN/AEI/10.13039/501100011033. . Внебюджетное финансирование.
  15. R01GM148702. . Внебюджетное финансирование.
  16. UMO-2021/41/B/NZ2/03036. . Внебюджетное финансирование.
  17. R35GM118070. . Внебюджетное финансирование.
  18. DP1GM146256. . Внебюджетное финансирование.
  19. JP24H02307. . Внебюджетное финансирование.
  20. 2219/22. . Внебюджетное финансирование.